Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
33 pending office actions • 19 art units • 33 examiners • 0 of 33 (0%) have an AI response strategy ready • 37 patents granted in the last 365 days
The United States Government AS Represented By The Department Of Veterans Af currently has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This prosecution is being conducted by 1 distinct examiner within 1 distinct art unit. The nature of this activity suggests a targeted patenting effort in this specific technical field.
The busiest examiner, PERREIRA, MELISSA JEAN, is responsible for 1 pending office action. This 1 pending action accounts for the pending volume for the company. Consequently, the immediate future of the portfolio's prosecution is dependent on the dialogue with the 1 distinct examiner and their interpretation of the biotechnology standards within the 1 distinct art unit.
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 4 (12%) |
| §103 only | 5 (15%) |
| §102 only | 1 (3%) |
| Double-patenting only | 2 (6%) |
| Double-patenting + other | 3 (9%) |
| Multi-statute (no §101) | 18 (55%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LOUIS, RICHARD G | 1 | 74.7% | +17.2% |
| PARK, EVELYN GRACE | 1 | 51.6% | +40.5% |
| CERIONI, DANIEL LEE | 1 | 64.5% | +28.0% |
| RAGHU, GANAPATHIRAM | 1 | 73.6% | +26.4% |
| GEBREMICHAEL, BRUK A | 1 | 22.1% | +23.4% |
| BAZARGANI, ARYA AHMADI | 1 | 62.5% | +31.3% |
| PIPIC, ALMA | 1 | 54.6% | +54.7% |
| GRASER, JENNIFER E | 1 | 76.7% | +23.4% |
| BRAUN, MADELINE E | 1 | 68.0% | +25.7% |
| PALLAY, MICHAEL B | 1 | 55.8% | +34.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18483225 | Combination Therapy for Treating or Preventing Depression or Other Mood Diseases | LEE, CHIHYI NMN | 18d overdue |
| 18478342 | SYSTEMS AND METHODS FOR HISTOTRIPSY IMMUNOSENSITIZATION | DEUTSCH, TAYLOR M | 40d |
| 19129959 | CATHETER AND METHODS OF USING SAME | LOUIS, RICHARD G | — |
| 19109022 | METHODS AND SYSTEMS FOR PREDICTING HEALTH RISKS | PARK, EVELYN GRACE | — |
| 18852356 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF STROKE | RAGHU, GANAPATHIRAM | — |
| 18812628 | METHODS AND KITS FOR DIAGNOSING, ASSESSING OR QUANTITATING DRUG USE, DRUG ABUSE AND NARCOSIS, INTERNUCLEAR OPHTHALMOPLEGIA, ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD), CHRONIC TRAUMATICENCEPH ALOPATHY,SCHIZOPHRENIA SPECTRUM DISORDERS AND ALCOHOL CONSUMPTION | GEBREMICHAEL, BRUK A | — |
| 18834436 | A MECHANO-RESPONSIVE NANOFIBROUS PATCH FOR THE DELIVERY OF BIOLOGICS IN LOAD-BEARING TISSUES | BAZARGANI, ARYA AHMADI | — |
| 18775053 | Diagnosis and Treatment of Metabolic Syndrome with Magnesium Compositions | PIPIC, ALMA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18644608 | MEK1/2 INHIBITOR-LOADED MICROPARTICLE FORMULATION | PALLAY, MICHAEL B | 40d |
| 19129959 | CATHETER AND METHODS OF USING SAME | LOUIS, RICHARD G | — |
| 19109022 | METHODS AND SYSTEMS FOR PREDICTING HEALTH RISKS | PARK, EVELYN GRACE | — |
| 18979814 | Methods And Kits For Assessing Central Nervous System Integrity | CERIONI, DANIEL LEE | — |
| 18852356 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF STROKE | RAGHU, GANAPATHIRAM | — |
| 18812628 | METHODS AND KITS FOR DIAGNOSING, ASSESSING OR QUANTITATING DRUG USE, DRUG ABUSE AND NARCOSIS, INTERNUCLEAR OPHTHALMOPLEGIA, ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD), CHRONIC TRAUMATICENCEPH ALOPATHY,SCHIZOPHRENIA SPECTRUM DISORDERS AND ALCOHOL CONSUMPTION | GEBREMICHAEL, BRUK A | — |
| 18834436 | A MECHANO-RESPONSIVE NANOFIBROUS PATCH FOR THE DELIVERY OF BIOLOGICS IN LOAD-BEARING TISSUES | BAZARGANI, ARYA AHMADI | — |
| 18775053 | Diagnosis and Treatment of Metabolic Syndrome with Magnesium Compositions | PIPIC, ALMA | — |
| Art Unit | Apps |
|---|---|
| 1658 | 3 |
| 1617 | 2 |
| 1626 | 2 |
| 1638 | 2 |
| 1628 | 2 |
| 1624 | 2 |
| 3791 | 2 |
| 3771 | 1 |
| 3715 | 1 |
| 1613 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19129959 | CATHETER AND METHODS OF USING SAME | LOUIS, RICHARD G | 3771 | §102§103 | Non-Final OA | — | Pending | May 14, 2025 |
| 19109022 | METHODS AND SYSTEMS FOR PREDICTING HEALTH RISKS | PARK, EVELYN GRACE | — | §101§102 | Non-Final OA | — | Pending | Mar 05, 2025 |
| 18979814 | Methods And Kits For Assessing Central Nervous System Integrity | CERIONI, DANIEL LEE | — | DP | Non-Final OA | — | Pending | Dec 13, 2024 |
| 18852356 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF STROKE | RAGHU, GANAPATHIRAM | — | §102§103§112 | Non-Final OA | — | Pending | Sep 27, 2024 |
| 18812628 | METHODS AND KITS FOR DIAGNOSING, ASSESSING OR QUANTITATING DRUG USE, DRUG ABUSE AND NARCOSIS, INTERNUCLEAR OPHTHALMOPLEGIA, ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD), CHRONIC TRAUMATICENCEPH ALOPATHY,SCHIZOPHRENIA SPECTRUM DISORDERS AND ALCOHOL CONSUMPTION | GEBREMICHAEL, BRUK A | 3715 | DP | Non-Final OA | — | Pending | Aug 22, 2024 |
| 18834436 | A MECHANO-RESPONSIVE NANOFIBROUS PATCH FOR THE DELIVERY OF BIOLOGICS IN LOAD-BEARING TISSUES | BAZARGANI, ARYA AHMADI | 1613 | §101§102§103§112 | Non-Final OA | — | Pending | Jul 30, 2024 |
| 18775053 | Diagnosis and Treatment of Metabolic Syndrome with Magnesium Compositions | PIPIC, ALMA | 1617 | §102§103§112 | Non-Final OA | — | Pending | Jul 17, 2024 |
| 18671007 | Non-Toxin Antigens For Clostridioides Difficile Vaccine | GRASER, JENNIFER E | 1645 | §101§102§112 | Non-Final OA | — | Pending | May 22, 2024 |
| 18710037 | METHOD OF TREATING CANCER ASSOCIATED WITH RAS MUTATION | BRAUN, MADELINE E | — | §102§103§112Other | Non-Final OA | — | Pending | May 14, 2024 |
| 18644608 | MEK1/2 INHIBITOR-LOADED MICROPARTICLE FORMULATION | PALLAY, MICHAEL B | 1617 | §103 | Final Rejection | 40d | Pending | Apr 24, 2024 |
| 18684563 | TREATMENT COMPOSITIONS AND METHODS | HEASLEY, MEGHAN CHRISTINE | 1626 | §102§103§112 | Non-Final OA | — | Pending | Feb 16, 2024 |
| 18417617 | COMPOSITIONS AND METHODS FOR SPATIAL AND TEMPORAL CONTROL OF NEUROTROPHIC GROWTH FACTOR EXPRESSION | AMICK, THOMAS RUSSE | 1638 | §102§103 | Non-Final OA | — | Pending | Jan 19, 2024 |
| 18573604 | Compounds For Molecular Imaging of Collagen Turnover and Methods Using Same | JONES, DAMERON LEVEST | — | §103§112 | Non-Final OA | — | Pending | Dec 22, 2023 |
| 18390242 | COMPOSITIONS AND METHOD FOR TREATING GUT PERMEABILITY CAUSED BY HYDROGEN SULFIDE PRODUCING BACTERIA | ABDALHAMEED, MANAHIL MIRGHANI ALI | 1622 | §103§112 | Non-Final OA | — | Pending | Dec 20, 2023 |
| 18533784 | COMPOSITIONS AND METHODS FOR TREATING RIGHT VENTRICLE DYSFUNCTION | ZARA, JANE J | 4100 | §102§103§112 | Non-Final OA | — | Pending | Dec 08, 2023 |
| 18566564 | METHODS AND COMPOSITIONS FOR LOCALIZATION OF GROWTH FACTORS | BERHANE, SELAM | — | §103§112 | Non-Final OA | — | Pending | Dec 01, 2023 |
| 18563088 | ANTI-OXIDANT CONTAINING PARTICLES AND METHODS OF USE | DAVIS, RUTH A | 1699 | §103§112DP | Non-Final OA | — | Pending | Nov 21, 2023 |
| 18555169 | ERYTHROPOIETIN-DERIVED PEPTIDES FOR TREATING RELAPSING-REMITTING MULTIPLE SCLEROSIS | KOMATSU, LI N | 1658 | §102§112DP | Non-Final OA | — | Pending | Oct 12, 2023 |
| 18483225 | Combination Therapy for Treating or Preventing Depression or Other Mood Diseases | LEE, CHIHYI NMN | 1628 | §103§112Other | Final Rejection | 18d overdue | Pending | Oct 09, 2023 |
| 18478342 | SYSTEMS AND METHODS FOR HISTOTRIPSY IMMUNOSENSITIZATION | DEUTSCH, TAYLOR M | 3798 | §102§103 | Final Rejection | 40d | Pending | Sep 29, 2023 |
| 18372662 | MUSCARINIC M2 RECEPTOR BLOCKADE TO DELAY OR PREVENT ONSET OF PROGRESSIVE MEMORY DECLINE | BORALSKY, LUKE ALAN | 1624 | §103§112DP | Non-Final OA | — | Pending | Sep 25, 2023 |
| 18547837 | OSTEOTROPIC COMPOSITIONS AND USES THEREOF | KATAKAM, SUDHAKAR | 1658 | §103 | Non-Final OA | — | Pending | Aug 24, 2023 |
| 18274293 | COMPOSITIONS AND METHODS FOR INHIBITING YAP | COUGHLIN, MATTHEW P | 1626 | §102§103§112 | Non-Final OA | — | Pending | Jul 26, 2023 |
| 18336712 | THE MODE OF ACTION OF N-MeDCPA ON TRPC CHANNELS | LEE, ANDREW P | 1691 | §102§103§112 | Non-Final OA | — | Pending | Jun 16, 2023 |
| 18195296 | Method for Reducing Ototoxicity in Pediatric Patients Receiving Plantinum-Based Chemotherapy | HOWELL, THEODORE R | 1628 | §103 | Final Rejection | 78d overdue | Pending | May 09, 2023 |
| 18043163 | HYDROXYNORKETAMINE COMPOUNDS AND METHODS OF USE THEREOF | RAO, PADMAJA S | 1627 | §102§103§112 | Non-Final OA | — | Pending | Feb 27, 2023 |
| 18164699 | NOVEL EFFICACIOUS MICRORNA-30C ANALOGS REDUCE APOLIPOPROTEIN B SECRETION IN HUMAN LIVER CELLS | CHONG, KIMBERLY | 1636 | §103 | Final Rejection | — | Pending | Feb 06, 2023 |
| 18075811 | PROVIDING MENTAL CONTROL OF POSITION AND/OR GESTURE CONTROLLED TECHNOLOGIES VIA INTENDED POSTURES | GOMES, SRISTI DIVINA | 3791 | §101§103 | Final Rejection | — | Pending | Dec 06, 2022 |
| 17980164 | MEDICAL TREATMENTS BY COGNITIVE DISCONNECTION | HONRATH, MARC D | 3791 | §102§112 | Non-Final OA | — | Pending | Nov 03, 2022 |
| 17842225 | METHODS FOR TREATING EYE DISEASE | VIVLEMORE, TRACY ANN | 1638 | §103 | Final Rejection | 28d overdue | Pending | Jun 16, 2022 |
| 17625059 | TREATMENT OF PULMONARY FIBROSIS USING INHIBITORS OF NEU1 SIALIDASE | COLEMAN, BRENDA LIBBY | 1624 | §102 | Non-Final OA | — | Pending | Jan 05, 2022 |
| 17609757 | COMPOSITIONS AND METHODS FOR TREATING CANCER | HADDAD, MAHER M | 1641 | §102§103Other | Non-Final OA | — | Pending | Nov 08, 2021 |
| 17518047 | METHOD FOR TREATING OPIOID USE DISORDER | COFFA, SERGIO | 1658 | §102§103§112 | Final Rejection | — | Pending | Nov 03, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial